These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 15980907

  • 1. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
    Wong ML.
    N Z Med J; 2005 Jun 24; 118(1217):U1533. PubMed ID: 15980907
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [What is certain in gout therapy?].
    Gottesbüren H, Strohmeyer G.
    Internist (Berl); 1971 Dec 24; 12(12):518-21. PubMed ID: 4945391
    [No Abstract] [Full Text] [Related]

  • 5. Drug treatment of gout.
    Kelley WN, Wyngaarden JB.
    Semin Drug Treat; 1971 Sep 24; 1(2):119-47. PubMed ID: 4949305
    [No Abstract] [Full Text] [Related]

  • 6. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
    Reinders MK, Haagsma C, Jansen TL, van Roon EN, Delsing J, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jun 24; 68(6):892-7. PubMed ID: 18633127
    [Abstract] [Full Text] [Related]

  • 7. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
    Simon HB.
    Harv Mens Health Watch; 2010 Jan 24; 14(6):7-8. PubMed ID: 20464796
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of the gout and other forms of crystal-induced arthritis.
    Rodnan GP.
    Bull Rheum Dis; 1982 Jan 24; 32(5):43-53. PubMed ID: 6762236
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jan 24; 68(1):51-6. PubMed ID: 18250112
    [Abstract] [Full Text] [Related]

  • 10. [Chronic gout. Case report of a severe course of disease].
    Boxberger F, Harsch IA, Brueckl WM, Hautmann M, Baum U, Hahn EG, Wein A.
    Med Klin (Munich); 2003 Nov 15; 98(11):646-7. PubMed ID: 14631540
    [No Abstract] [Full Text] [Related]

  • 11. [Early diagnosis and early treatment of gout].
    Mertz DP.
    Hippokrates; 1968 Jan 15; 39(1):5-12. PubMed ID: 5667616
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P, Akkasilpa S, Deesomchok U.
    J Med Assoc Thai; 2002 Jun 15; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S, Osiri M, Deesomchok U, Avihingsanon Y.
    J Med Assoc Thai; 2004 Sep 15; 87(9):1087-91. PubMed ID: 15516011
    [Abstract] [Full Text] [Related]

  • 14. [Isolated or combined drug therapy of hyperuricemia?].
    Mertz DP.
    Dtsch Med Wochenschr; 1977 Jul 29; 102(30):1096-7. PubMed ID: 891391
    [No Abstract] [Full Text] [Related]

  • 15. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A.
    Arthritis Rheum; 2002 Aug 29; 47(4):356-60. PubMed ID: 12209479
    [Abstract] [Full Text] [Related]

  • 16. Pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ.
    J Maine Med Assoc; 1979 Mar 29; 70(3):118-20, 122-7. PubMed ID: 374661
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
    Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, García-Erauskin G, Ruiz-Lucea E.
    Ann Rheum Dis; 1998 Sep 29; 57(9):545-9. PubMed ID: 9849314
    [Abstract] [Full Text] [Related]

  • 18. The management of gout.
    Emmerson BT.
    Med J Aust; 1972 Mar 04; 1(10):475-8. PubMed ID: 5024419
    [No Abstract] [Full Text] [Related]

  • 19. [Benziodarone in the basic treatment of gout].
    Ryckewaert A, Puel M, Kuntz D.
    Rev Rhum Mal Osteoartic; 1972 Jan 04; 39(1):33-9. PubMed ID: 5079688
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
    Reinders MK, van Roon EN, Houtman PM, Brouwers JR, Jansen TL.
    Clin Rheumatol; 2007 Sep 04; 26(9):1459-65. PubMed ID: 17308859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.